Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M. Tateyama
190P Observational Cohort Study of 1st Line Bevacizumab Combined With Chemotherapy in Metastatic Colorectal Cancer (HGCSG0802): Sub-Group Analysis by the Glasgow Prognostic Score (GPS)
Annals of Oncology
Medicine
Oncology
Hematology
Related publications
Bevacizumab in First-Line Treatment of Elderly Patients With Metastatic Colorectal Cancer: German Community-Based Observational Cohort Study Results
BMC Cancer
Cancer Research
Oncology
Genetics
Discontinuation of First-Line Bevacizumab in Metastatic Colorectal Cancer: The BEAWARE Italian Observational Study
Tumori
Medicine
Cancer Research
Oncology
The Clinical Benefit of Bevacizumab in Metastatic Colorectal Cancer Is Independent of K-Ras Mutation Status: Analysis of a Phase III Study of Bevacizumab With Chemotherapy in Previously Untreated Metastatic Colorectal Cancer
Oncologist
Cancer Research
Medicine
Oncology
Adverse Events Associated With Bevacizumab and Chemotherapy in Older Patients With Metastatic Colorectal Cancer
Clinical Colorectal Cancer
Oncology
Gastroenterology
Glasgow Prognostic Score (GPS) Can Be a Useful Indicator to Determine Prognosis of Patients With Colorectal Carcinoma
International Surgery
Surgery
Evaluation of an Inflammation-Based Prognostic Score (GPS) in Patients With Metastatic Breast Cancer
British Journal of Cancer
Cancer Research
Oncology
Hypertension and Overall Survival in Metastatic Colorectal Cancer Patients Treated With Bevacizumab-Containing Chemotherapy
British Journal of Cancer
Cancer Research
Oncology
Metastatic Colorectal Cancer First-Line Treatment With Bevacizumab: The Impact of K-Ras Mutation
OncoTargets and Therapy
Oncology
Pharmacology
Effect of Application and Intensity of Bevacizumab-Based Maintenance After Induction Chemotherapy With Bevacizumab for Metastatic Colorectal Cancer: A Meta-Analysis
Clinical Colorectal Cancer
Oncology
Gastroenterology
